Andries Pretorius , Adrian Kelly , Patrick Lekgwara
{"title":"Evaluating the incidence and risk factors for ventriculoperitoneal shunt sepsis at Dr George Mukhari Academic hospital in Pretoria, South Africa","authors":"Andries Pretorius , Adrian Kelly , Patrick Lekgwara","doi":"10.1016/j.inat.2025.102067","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Patients with increased pressure hydrocephalus are a common referral to the Department of Neurosurgery at our institution.</div></div><div><h3>Materials and methods</h3><div>A descriptive cross-sectional study performed by consecutively enrolling 335 subjects who underwent a ventriculoperitoneal shunt insertion between the 01 January 2014 – 30 November 2022, aimed to establish our local ventriculoperitoneal shunt sepsis incidence, and further evaluate the known risk factors for ventriculoperitoneal shunt sepsis at 3- month follow-up.</div></div><div><h3>Results</h3><div>In our study 335 ventriculoperitoneal shunts were inserted, 190 (57 %) were inserted in children and 145 (43 %) were inserted in adults. With regards the cause of hydrocephalus in 90/335 (26.9 %) subjects this was congenital, in 45/335 (13 %) subjects this was a primary intra-axial CNS tumor, in 40/335 (12 %) subjects this was intraventricular hemorrhage, and in 38/335 (11 %) subjects this was in subjects with a myelomeningocele. Considering the ventriculoperitoneal shunt infection incidence 28/335 (8.4 %) subjects developed this complication within 3 months of the procedure. In evaluating the significance of the known risk factors for ventriculoperitoneal shunt sepsis, our study demonstrated that having a ventriculoperitoneal shunt insertion performed in the emergency theatre (p = 0.02, OR 1.87, CI 0.83–4.23), having a ventriculoperitoneal shunt inserted at night (p = 0.03, OR 3.92, CI 1.13–13.58), having a history of ventriculoperitoneal shunt sepsis (p = 0.004, OR 7.34, CI 2.20–24.55), being clinically immunosuppressed at the time of the ventriculoperitoneal shunt insertion procedure (p = 0.03, OR 3.01, CI 1.09–8.32), and having a post-operative cerebrospinal fluid leak (p = 0.04, OR 5.19, CI 0.91–29.71), demonstrated significance in predicting that ventriculoperitoneal shunt sepsis would occur.</div></div><div><h3>Conclusion</h3><div>Our study confirmed that our institutional ventriculoperitoneal shunt sepsis rate is 8.4 % and furthermore confirmed the significance of several of the known risk factors as taken from the literature.</div></div>","PeriodicalId":38138,"journal":{"name":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","volume":"40 ","pages":"Article 102067"},"PeriodicalIF":0.4000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary Neurosurgery: Advanced Techniques and Case Management","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214751925000799","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Patients with increased pressure hydrocephalus are a common referral to the Department of Neurosurgery at our institution.
Materials and methods
A descriptive cross-sectional study performed by consecutively enrolling 335 subjects who underwent a ventriculoperitoneal shunt insertion between the 01 January 2014 – 30 November 2022, aimed to establish our local ventriculoperitoneal shunt sepsis incidence, and further evaluate the known risk factors for ventriculoperitoneal shunt sepsis at 3- month follow-up.
Results
In our study 335 ventriculoperitoneal shunts were inserted, 190 (57 %) were inserted in children and 145 (43 %) were inserted in adults. With regards the cause of hydrocephalus in 90/335 (26.9 %) subjects this was congenital, in 45/335 (13 %) subjects this was a primary intra-axial CNS tumor, in 40/335 (12 %) subjects this was intraventricular hemorrhage, and in 38/335 (11 %) subjects this was in subjects with a myelomeningocele. Considering the ventriculoperitoneal shunt infection incidence 28/335 (8.4 %) subjects developed this complication within 3 months of the procedure. In evaluating the significance of the known risk factors for ventriculoperitoneal shunt sepsis, our study demonstrated that having a ventriculoperitoneal shunt insertion performed in the emergency theatre (p = 0.02, OR 1.87, CI 0.83–4.23), having a ventriculoperitoneal shunt inserted at night (p = 0.03, OR 3.92, CI 1.13–13.58), having a history of ventriculoperitoneal shunt sepsis (p = 0.004, OR 7.34, CI 2.20–24.55), being clinically immunosuppressed at the time of the ventriculoperitoneal shunt insertion procedure (p = 0.03, OR 3.01, CI 1.09–8.32), and having a post-operative cerebrospinal fluid leak (p = 0.04, OR 5.19, CI 0.91–29.71), demonstrated significance in predicting that ventriculoperitoneal shunt sepsis would occur.
Conclusion
Our study confirmed that our institutional ventriculoperitoneal shunt sepsis rate is 8.4 % and furthermore confirmed the significance of several of the known risk factors as taken from the literature.
高压性脑积水患者是我院神经外科的常见转诊病例。材料和方法一项描述性横断面研究,在2014年1月1日至2022年11月30日期间连续纳入335名接受脑室-腹膜分流术的受试者,旨在确定我国局部脑室-腹膜分流术脓毒症的发生率,并在3个月的随访中进一步评估脑室-腹膜分流术脓毒症的已知危险因素。结果本研究共置入335例脑室-腹膜分流管,其中儿童190例(57%),成人145例(43%)。关于脑积水的原因,90/335(26.9%)的受试者为先天性,45/335(13%)的受试者为原发性轴内中枢神经系统肿瘤,40/335(12%)的受试者为脑室内出血,38/335(11%)的受试者为脊膜膨出。考虑到脑室-腹腔分流术感染的发生率,28/335(8.4%)的受试者在手术后3个月内出现了这种并发症。在评估脑室-腹膜分流器脓毒症已知危险因素的重要性时,我们的研究表明,在急诊室进行脑室-腹膜分流器置入(p = 0.02, OR 1.87, CI 0.83-4.23)、在夜间置入脑室-腹膜分流器(p = 0.03, OR 3.92, CI 1.13-13.58)、有脑室-腹膜分流器脓毒症病史(p = 0.004, OR 7.34, CI 2.20-24.55)、在脑室-腹膜分流术插入时临床免疫抑制(p = 0.03, OR 3.01, CI 1.09-8.32),以及术后脑脊液漏(p = 0.04, OR 5.19, CI 0.91-29.71),在预测脑室-腹膜分流术败血症发生方面具有重要意义。结论我们的研究证实了我们的机构脑室腹腔分流脓毒症发生率为8.4%,进一步证实了文献中几个已知危险因素的重要性。